In the original publication [1], there was a mistake in Figure 1 as published. Figure 1E (OX/PEG-CS NPs) was unintentionally assembled using a magnified image of AA-OX/PEG-CS NPs (Figure 1F). This duplication occurred during figure assembly, when magnified images from the same TEM session were organized, and panel E was mistakenly replaced. The corrected Figure 1 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 1.
TEM images for (A) AA/CS NPs, (B) OX/CS NPs, (C) AA-OX/CS NPs, (D) AA/PEG-CS NPs, (E) OX/PEG-CS NPs, and (F) AA-OX/PEG-CS NPs. The arrow shows the PEG layer coating the CS NPs.
Reference
- Fahmy, S.A.; Ramzy, A.; Mandour, A.A.; Nasr, S.; Abdelnaser, A.; Bakowsky, U.; Azzazy, H.M.E.-S. PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells. Pharmaceutics 2022, 14, 407. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.